6.09 The exhibit index has a '^' footnote on omitted schedules that no exhibit number carries

Company H · a US-listed aerospace services company · Drafting slip

DraftingLowEstablishedCover page, exhibits, XBRL and other disclosures
Area of the 10-K
Item 15, exhibit index footnotes
Year
Both years
Status
Established: Established from the company’s own documents; the requirement is clear.
Who acts
SEC Reporting, General Counsel
When
Form 10-K for fiscal 2026

In brief

The exhibit index ends with a '^' footnote saying schedules were left out of an exhibit under Item 601(a)(5) of Regulation S-K, but no exhibit number in the index carries the '^' mark, so the reader cannot tell which agreement it refers to. The 2024 Form 10-K had the same unattached footnote.

The evidence, as filed

Masked extract: Form 10-K 2025, page 142
Form 10-K 2025, page 142The '^' footnote under the exhibit index
Masked extract: Form 10-K 2025, page 141
Form 10-K 2025, page 141The exhibit index rows, none of which carries a '^' mark
Masked extract: Form 10-K 2025, page 141. Where the disclosure should appear: nothing here
Form 10-K 2025, page 141Where the disclosure should appear: nothing hereWhere the item should appear: a '^' mark against the exhibit whose schedules were left out is not shown here
Masked extract: Form 10-K 2024 (prior year), page 135. The prior-year filing
Form 10-K 2024 (prior year), page 135The prior-year filingPrior year: The 2024 Form 10-K exhibit index carried the same footnote, also with no exhibit marked.

What the filing shows, and what the rule requires

What the filing showsWhat the rule requires

Footnote '^ Schedules have been omitted pursuant to Item 601(a)(5)' with no '^' against any exhibit number

The '^' mark placed against the exhibit whose schedules were left out (for example the credit agreement, if that is the one), or the footnote deleted

Why it matters

A reader cannot tell which filed agreement is incomplete.

Exposure

Drafting only.

Our workings

Fact

the footnote list under the exhibit index includes a '^' note on schedules left out under Item 601(a)(5) of Regulation S-K, and no exhibit row on the two index pages carries the '^' mark. The 2024 Form 10-K's index had the same footnote, also unattached.

Our inference

the mark was dropped from the relevant exhibit row when the index was rolled forward.

Management’s best defense, and our reply

The company would say the omission statement and list of schedules sit in the exhibit itself as originally filed, so nothing is hidden. That may be so, but the index footnote still points at nothing.

The fix

  1. Place '^' against the exhibit concerned (or delete the footnote).

Evidence relied on

#What it showsTypeWhere
1The '^' footnote under the exhibit indexDocumentForm 10-K 2025, page 142
2The exhibit index rows, none of which carries a '^' markDocumentForm 10-K 2025, page 141

Absence check

Document
Form 10-K 2025
Where it would appear
Exhibit Index
What is missing
a '^' mark against the exhibit whose schedules were left out
Pages looked at
p.141-142
Result
Each term hits the footnote itself on p.142; 'Schedules have been omitted' also hits p.140, the Item 15(a)(2) statement that financial statement schedules are omitted, which is unrelated; the '^' character occurs only once in the filed text, so no exhibit row on p.141-142 carries the mark

Prepared by Pramanex from the company’s public SEC filings, without the company’s involvement, to show how a 10-K Pre-filing Check reads. The company is not named, and nothing on this page is a statement about any identifiable company. Observations are not an audit, review or other attestation or assurance engagement, and not legal advice. An SEC-style question is a question, not a conclusion.

Want this on your own 10-K, before you file?

Start with three free findings on your latest 10-K, or book a fixed-price 10-K Pre-filing Check.

Your next 10-K will be in draft before the audit is done.
Have it read before you file.

Start with three free findings on your latest 10-K, or book a fixed-price 10-K check. Drafts only under NDA, inside your insider trading policy.